Search

everythinglearnresearchcommunity

for

Search:↓

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

A man's gray hair got darker and thicker after using a psoriasis drug.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Minoxidil may help treat hair loss by reducing inflammation-related gene activity in skin cells.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Blocking interferon-gamma might help treat various autoimmune diseases.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

IL-36α helps grow new hair follicles and speeds up wound healing.

A herbal extract may help treat certain types of hair loss by reducing a specific gene's activity.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Pregnancy right after giving birth in mice lacking IL-10 causes milk that leads to liver issues and hair loss in their babies.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Lokivetmab reduced itching in a dog with skin lymphoma.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.